Abstract
Chiral 3-substituted-4-amino-5-thioxo-1H,4H-1,2,4-triazoles (5a-i) were synthesized. The target molecules were prepared by cyclization of the corresponding dithiocarbazinic acids, obtained from hydrazides, in the presence of hydrazine hydrate. The chiral hydrazides were in turn synthesized form L-amino acids. The structures of all the compounds were confirmed by modern spectroscopic techniques and purity ascertained by elemental analysis. The synthesized compounds 5a-i were evaluated for urease inhibition and found to exhibit varying degrees of urease inhibition activity showing IC50 values ranging from 22.0 ± 0.5 to 43.8 ± 0.3 μM. Compound 5b was found to be the most active, exhibiting IC50 = 22.0 ± 0.5 μM comparable to the standard, thiourea (IC50 = 21.0 ± 0.1 μM). Triazoles 5a-i were also screened for their antimicrobial properties and promising antibacterial activities were observed against five pathogenic bacteria. However, all the compounds were devoid of any antifungal activity.
Keywords: Chiral triazoles, synthesis, antibacterial activity, urease inhibition
Medicinal Chemistry
Title: Syntheses, Urease Inhibition, and Antimicrobial Studies of Some Chiral 3-Substituted-4-amino-5-thioxo-1H,4H-1,2,4-triazoles
Volume: 4 Issue: 6
Author(s): Tashfeen Akhtar, Shahid Hameed, Khalid Mohammed Khan and Muhammad Iqbal Choudhary
Affiliation:
Keywords: Chiral triazoles, synthesis, antibacterial activity, urease inhibition
Abstract: Chiral 3-substituted-4-amino-5-thioxo-1H,4H-1,2,4-triazoles (5a-i) were synthesized. The target molecules were prepared by cyclization of the corresponding dithiocarbazinic acids, obtained from hydrazides, in the presence of hydrazine hydrate. The chiral hydrazides were in turn synthesized form L-amino acids. The structures of all the compounds were confirmed by modern spectroscopic techniques and purity ascertained by elemental analysis. The synthesized compounds 5a-i were evaluated for urease inhibition and found to exhibit varying degrees of urease inhibition activity showing IC50 values ranging from 22.0 ± 0.5 to 43.8 ± 0.3 μM. Compound 5b was found to be the most active, exhibiting IC50 = 22.0 ± 0.5 μM comparable to the standard, thiourea (IC50 = 21.0 ± 0.1 μM). Triazoles 5a-i were also screened for their antimicrobial properties and promising antibacterial activities were observed against five pathogenic bacteria. However, all the compounds were devoid of any antifungal activity.
Export Options
About this article
Cite this article as:
Akhtar Tashfeen, Hameed Shahid, Khan Mohammed Khalid and Choudhary Iqbal Muhammad, Syntheses, Urease Inhibition, and Antimicrobial Studies of Some Chiral 3-Substituted-4-amino-5-thioxo-1H,4H-1,2,4-triazoles, Medicinal Chemistry 2008; 4 (6) . https://dx.doi.org/10.2174/157340608786242025
DOI https://dx.doi.org/10.2174/157340608786242025 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular and Genetic Bases of Pancreatic Cancer
Current Drug Targets Roles of Natural Compounds from Medicinal Plants in Cancer Treatment: Structure and Mode of Action at Molecular Level
Medicinal Chemistry Polymer-Based Drug Delivery Systems, Development and Pre-Clinical Status
Current Pharmaceutical Design Catechol-O-Methyltransferase (COMT)-Mediated Methylation Metabolism of Endogenous Bioactive Catechols and Modulation by Endobiotics and Xenobiotics: Importance in Pathophysiology and Pathogenesis
Current Drug Metabolism Bacterial Urease and its Role in Long-Lasting Human Diseases
Current Protein & Peptide Science Intestinal Drug Transporters: In Vivo Function and Clinical Importance
Current Drug Metabolism Thioethers: An Overview
Current Drug Targets Disease-Related Changes in TRPV1 Expression and Its Implications for Drug Development
Current Topics in Medicinal Chemistry Lactoferrin Derived Peptides: Mechanisms of Action and their Perspectives as Antimicrobial and Antitumoral Agents
Mini-Reviews in Medicinal Chemistry Antisynthetase Syndrome: A Review of Etiopathogenesis, Diagnosis and Management
Current Medicinal Chemistry The Implications of Human Stem Cell Differentiation to Endothelial Cell Via Fluid Shear Stress in Cardiovascular Regenerative Medicine: A Review
Current Pharmaceutical Design Multidimensional Role of Inulin as Synbiotic, Drug Carrier and Synergistic Adjuvant for the Colonic Delivery of 5-FU
Drug Delivery Letters Studies on the Preparation and Evaluation of Antimalarial activity of Arteether and Complexed Arteether with β-CD Loaded Chitosan/Lecithin Nanoparticles
Pharmaceutical Nanotechnology General Principles of Photodynamic Therapy (PDT) and Gastrointestinal Applications
Current Pharmaceutical Biotechnology Therapeutic Potential of Natural Compounds that Regulate the Activity of Protein Kinase C
Current Medicinal Chemistry Synergistic Two-Way Interactions of Dietary Polyphenols and Dietary Components on the Gut Microbial Composition: Is There a Positive, Negative, or Neutralizing Effect in the Prevention and Management of Metabolic Diseases?
Current Protein & Peptide Science Chitosan: A Propitious Biopolymer for Drug Delivery
Current Drug Delivery Therapeutic Strategies for Targeting BRAF in Human Cancer
Reviews on Recent Clinical Trials Adenosine Receptors: What We Know and What We are Learning
Current Topics in Medicinal Chemistry Lgr5 Contributes to Intestinal Metaplasia During Gastric Carcinogenesis: A Meta analysis
Anti-Cancer Agents in Medicinal Chemistry